RPRX (RPRX) Stock Price & Analysis
RPRX (RPRX) rose 0.00% to USD 58.83 as of July 25, 2026 at 01:46 UTC, according to Nexqual real-time market data.
RPRX last closed at USD 58.83; the session ranged USD 58.51–59.72 on volume of 2,113,812 shares. Market capitalization is —, with a 52-week range of USD 34.08–59.72 (NMS). Source: Nexqual, July 25, 2026 at 01:46 UTC.
Key Statistics (as of July 25, 2026 at 01:46 UTC)
| Price | USD 58.83 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 58.83 |
| Open | USD 58.83 |
| Day Range | USD 58.51 – 59.72 |
| 52-Week Range | USD 34.08 – 59.72 |
| Volume | 2,113,812 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (RPRX)
Nexqual's technical model rates RPRX "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:46 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.93 (neutral) |
| vs SMA50 | Above (USD 55.49) |
| MACD | 1.01 (positive) |
From RPRX's Latest SEC 10-K Filing (filed 2026-02-11)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GTM | ZoomInfo Technologies Inc. | USD 2.92 | ▲ 0% |
| NCNO | nCino, Inc. | USD 16.56 | ▼ 0.24% |
| CYTK | Cytokinetics, Incorporated | USD 80.74 | ▼ 1.76% |
| GDRX | GoodRx Holdings, Inc. | USD 2.96 | ▲ 1.02% |
| ALNY | Alnylam Pharmaceuticals, Inc. | USD 271.77 | ▲ 1.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:46 UTC. This page is informational and not investment advice.